CFTR modulator therapy partially resolves inflammation in CF lung disease

被引：0
|
作者：
Maher, Rosemary [1 ]
Barry, Peter [2 ]
Emmott, Edward [1 ]
Jones, Andrew [2 ]
Lin, Lijing [3 ]
Mcnamara, Paul [4 ]
Smith, Jaclyn [5 ]
Lord, Robert [2 ]
机构：
[1] Univ Liverpool, Ctr Proteome Res, Liverpool, Merseyside, England
[2] Manchester Univ NHS Fdn Trust, Manchester Adult CF Ctr, Manchester, Lancs, England
[3] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England
[4] Univ Liverpool, Dept Child Hlth, Inst Pk, Liverpool, Merseyside, England
[5] Manchester Univ NHS Fdn Trust, Dept Resp Med, Manchester, Lancs, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2964
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CFTR, NEUTROPHILS, INFLAMMATION AND THE LUNG IN CF
    Tirouvanziam, Rabindra
    PEDIATRIC PULMONOLOGY, 2014, 49 : 203 - 204
  • [2] Treatment With LAU-7b Complements CFTR Modulator Therapy by Improving Lung Physiology and Normalizing Lipid Imbalance Associated With CF Lung Disease
    Centorame, Amanda
    Dumut, Daciana Catalina
    Youssef, Mina
    Ondra, Martin
    Kianicka, Irenej
    Shah, Juhi
    Paun, Radu Alexandru
    Ozdian, Tomas
    Hanrahan, John W.
    Gusev, Ekaterina
    Petrof, Basil
    Hajduch, Marian
    Pislariu, Radu
    De Sanctis, Juan Bautista
    Radzioch, Danuta
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] CFTR is a modulator of airway inflammation
    Rubin, Bruce K.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007, 292 (02) : L381 - L382
  • [4] How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored?
    Ben-Meir, Elad
    Grasemann, Hartmut
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (03) : 240 - 242
  • [5] Very Early Triple CFTR Modulator Therapy in a Child with Severe Structural Lung Disease
    Menard, J.
    Bui, S.
    Galode, F.
    Gallet, P.
    Fayon, M.
    Beaufils, F. B.
    PEDIATRIC PULMONOLOGY, 2023, 58 : S115 - S116
  • [6] PLASMA MIR-145: A NOVEL BIOMARKER OF CF LUNG DISEASE RELEVANT TO CFTR EXPRESSION AND MODULATOR RESPONSE
    Kabir, F. L.
    Ambalavanan, N.
    Rowe, S.
    Harris, W. T.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S347 - S348
  • [7] ASSOCIATION OF CFTR MODULATOR THERAPY PRESCRIPTION AND MENTAL HEALTH CHANGES IN INDIVIDUALS WITH CF
    Frederick, C. A.
    Fries, L. M.
    Roach, C.
    Cogswell, A.
    Goetz, D. M.
    Smith, B.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 423 - 423
  • [8] Pregnancy outcomes in CF before and after introduction of CFTR gene modulator therapy
    Cade, Ruth
    Watson, Rebecca
    Ahmed, Mahin
    Nazareth, Dilip
    Cox, David
    Dickins, Dyan
    Howie, Fiona
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [9] The impact of CFTR modulator therapy on body composition in patients with cystic fibrosis and advanced lung disease
    Dugac, Andrea Vukic
    Josic, Lucija
    Jelavic, Martina
    Banic, Marko
    Bambir, Ivan
    Tjesic-Drinkovic, Duska
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] INITIATION OF TRIPLE COMBINATION CFTR MODULATOR THERAPY IN PATIENTS WITH ADVANCED CYSTIC FIBROSIS LUNG DISEASE
    Uluer, A. Z.
    Fowler, R. E.
    Mwangi, I. M.
    Shin, K.
    Cardoni, L.
    Regan, K.
    Hui, M.
    Marchetti, P.
    Cernadas, M.
    Freedman, S.
    Sawicki, G. S.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S293 - S293
12345